UK experience of liver transplantation for erythropoietic protoporphyria

Journal of Inherited Metabolic Disease

Volumn 34, Issue 2, 2011, Pages 539-545

  Dowman, Joanna K ^a   Gunson, Briget K ^a,b   Mirza, Darius F ^b   Badminton, Mike N ^c   Newsome, Philip N ^a  

^a University Hospital Birmingham NHS Foundation Trust   (United Kingdom)

^b QUEEN ELIZABETH HOSPITAL   (United Kingdom)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; TACROLIMUS;

ADOLESCENT; ADULT; ARTICLE; BILE DUCT OBSTRUCTION; CLINICAL ARTICLE; DEATH; DISEASE REGISTRY; ERYTHROPOIETIC PROTOPORPHYRIA; FEMALE; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; HUMAN TISSUE; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; OUTCOME ASSESSMENT; RECURRENT DISEASE; SURVIVAL TIME; TREATMENT INDICATION; TREATMENT OUTCOME; UNITED KINGDOM;

ADOLESCENT; ADULT; BONE MARROW TRANSPLANTATION; FEMALE; GREAT BRITAIN; HUMANS; LIVER FAILURE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; PROTOPORPHYRIA, ERYTHROPOIETIC; RECURRENCE; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 79955694697     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-010-9272-6     Document Type: Article

References (33)

1. Anstey AV, Hift RJ (2007) Liver disease in erythropoietic protoporphyria: insights and implications for management. Gut 56 (7):1009-1018 (Pubitemid 46999088)
2. Appelbaum FR (2003) The current status of hematopoietic cell transplantation. Annu Rev Med 54:491-512
3. Avner DL, Lee RG, Berenson MM (1981) Protoporphyrin-induced cholestasis in the isolated in situ perfused rat liver. J Clin Invest 67(2):385-394 (Pubitemid 11141719)
4. Avner DL, Larsen R, Berenson MM (1983) Inhibition of liver surface membrane Na+, K+-adenosine triphosphatase, Mg+2- adenosine triphosphatase and 5′-nucleotidase activities by protoporphyrin. Observations in vitro and in the perfused rat liver. Gastroenterology 85(3):700-706 (Pubitemid 13033131)
5. Dellon ES, Szczepiorkowski ZM, Dzik WH, Graeme-Cook F, Ades A, Bloomer JR, Cosimi AB, Chung RT (2002) Treatment of recurrent allograft dysfunction with intravenous hematin after liver transplantation for erythropoietic protoporphyria. Transplantation 73(6):911-915 (Pubitemid 34252354)
6. Do KD, Banner BF, KATZ E, Szymanski IO, Bonkovsky HL (2002) Benefits of chronic plasmapheresis and intravenous hemealbumin in erythropoietic protoporphyria after orthotopic liver transplantation. Transplantation 73(3):469-472 (Pubitemid 34174300)
7. Dobozy A, Csato M, Siklosi C, Simon N (1983) Transfusion therapy for erythropoietic protoporphyria. Br J Dermatol 109 (5):571-576 (Pubitemid 14245065)
8. Doss MO, Frank M (1989) Hepatobiliary implications and complications in protoporphyria, a 20-year study. Clin Biochem 22(3):223-229 (Pubitemid 19162808)
9. Eichbaum QG, Dzik WH, Chung RT, Szczepiorkowski ZM (2005) Red blood cell exchange transfusion in two patients with advanced erythropoietic protoporphyria. Transfusion 45(2):208-213 (Pubitemid 40180137)
10. Elder GH, Gouya L, Whatley SD, Puy H, Badminton MN, Deybach JC (2009) The molecular genetics of erythropoietic protoporphyria. Cell Mol Biol (Noisy le grand) 55(2):118-126
11. Fontanellas A et al. (2000) Reversion of hepatobiliary alterations By bone marrow transplantation in a murine model of erythropoietic protoporphyria. Hepatology 32(1):73-81 (Pubitemid 30432368)
12. Freeman RB Jr (2008) Model for end-stage liver disease (MELD) for liver allocation: a 5-year score card. Hepatology 47(3):1052-1057
13. Herbert A, Corbin D, Williams A, Thompson D, Buckels J, Elias E (1991) Erythropoietic protoporphyria: unusual skin and neurological problems after liver transplantation. Gastroenterology 100 (6):1753-1757
14. Holme SA, Anstey AV, Finlay AY, Elder GH, Badminton MN (2006) Erythropoietic protoporphyria in the U.K.: clinical features and effect on quality of life. Br J Dermatol 155(3):574-581 (Pubitemid 44215489)
15. Leonardi MI, Ataide EC, Boin IF, Leonardi LS (2005) Role of choledochojejunostomy in liver transplantation. Transplant Proc 37(2):1126-1128 (Pubitemid 40590812)
16. McGuire BM et al. (2005) Liver transplantation for erythropoietic protoporphyria liver disease. Liver Transpl 11(12):1590-1596 (Pubitemid 43072638)
17. Meerman L 2000 Erythropoietic protoporphyria. An overview with emphasis on the liver. Scand J Gastroenterol Suppl, no. 232, p. 79-85
18. Meerman L et al. (1999) Biliary fibrosis associated with altered bile composition in a mouse model of erythropoietic protoporphyria. Gastroenterology 117(3):696-705 (Pubitemid 29409257)
19. Morton KO, Schneider F, Weimer MK, Straka JG, Bloomer JR (1988) Hepatic and bile porphyrins in patients with protoporphyria and liver failure. Gastroenterology 94(6):1488-1492
20. Neuberger J, Gimson A, Davies M, Akyol M, O'Grady J, Burroughs A, Hudson M (2008) Selection of patients for liver transplantation and allocation of donated livers in the UK. Gut 57(2):252-257 (Pubitemid 351158055)
21. Rand EB, Bunin N, Cochran W, Ruchelli E, Olthoff KM, Bloomer JR (2006) Sequential liver and bone marrow transplantation for treatment of erythropoietic protoporphyria. Pediatrics 118(6): e1896-e1899 (Pubitemid 46397595)
22. Reichheld JH, KATZ E, Banner BF, Szymanski IO, Saltzman JR, Bonkovsky HL (1999) The value of intravenous heme-albumin and plasmapheresis in reducing postoperative complications of orthotopic liver transplantation for erythropoietic protoporphyria. Transplantation 67(6):922-928 (Pubitemid 29169142)
23. Samuel D, Boboc B, Bernuau J, BISMUTH H, Benhamou JP (1988) Liver transplantation for protoporphyria. Evidence for the predominant role of the erythropoietic tissue in protoporphyrin overproduction. Gastroenterology 95(3):816-819
24. Seth AK, Badminton MN, Mirza D, Russell S, Elias E (2007) Liver transplantation for porphyria: who, when, and how? Liver Transpl 13(9):1219-1227
25. Spiva DA, Lewis CE (1984) Erythropoietic protoporphyria: therapeutic response to combined erythrocyte exchange and plasmapheresis. Photodermatology 1(5):211-220 (Pubitemid 15224445)
26. Todd DJ (1994) Erythropoietic protoporphyria. Br J Dermatol 131 (6):751-766
27. van der Meulen JH, Lewsey JD, Dawwas MF, Copley LP (2007) Adult orthotopic liver transplantation in the United Kingdom and Ireland between 1994 and 2005. Transplantation 84(5):572-579
28. van Wijk HJ, van Hattum J, Baart de la Faille H, van den Berg JW, Edixhoven-Bosdijk A, Wilson JH (1988) Blood exchange and transfusion therapy for acute cholestasis in protoporphyria. Dig Dis Sci 33(12):1621-1625
29. Wahlin S, Aschan J, Bjornstedt M, Broome U, Harper P (2007) Curative bone marrow transplantation in erythropoietic protoporphyria after reversal of severe cholestasis. J Hepatol 46(1):174-179 (Pubitemid 44827428)
30. Wahlin S, Srikanthan N, Hamre B, Harper P, Brun A (2008) Protection from phototoxic injury during surgery and endoscopy in erythropoietic protoporphyria. Liver Transpl 14 (9):1340-1346
31. Welling TH, Heidt DG, Englesbe MJ, Magee JC, Sung RS, Campbell DA, Punch JD, Pelletier SJ (2008) Biliary complications following liver transplantation in the model for end-stage liver disease era: effect of donor, recipient, and technical factors. Liver Transpl 14(1):73-80 (Pubitemid 351167992)
32. Whatley SD, Mason NG, Khan M, Zamiri M, Badminton MN, Missauoi WN, Dailey TA, Dailey HA, Stewart Douglas W, Wainwright NJ, Elder GH (2004) Autosomal recessive erythropoietic protoporphyria in the United Kingdom: prevalence and relationship to liver disease. J Med Genet 41(8):e105
33. Whatley SD et al. (2008) C-terminal deletions in the ALAS2 gene lead to gain of function and cause X-linked dominant protoporphyria without anemia or iron overload. Am J Hum Genet 83 (3):408-414